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In 1889, Paget launched the ‘seed and
soil’ hypothesis, which postulated that dis-
seminated cancer cells—the ‘seeds’—can
spread throughout the body but will pref-
erentially metastasize to specific organs
that provide congenial ‘soil’, the so-called
metastatic niche.1 For instance, breast can-
cer preferably metastasizes to the liver and
the bone.1 The transition from in situ to
invasive breast cancer may show some
likenesses with this ‘seed and soil’ hypoth-
esis for metastatic breast cancer. Ductal
carcinoma in situ (DCIS) is a clonal pro-
liferation of transformed epithelial cells,
confined to the ductal-lobular system
without evidence for disruption of the
basement membrane and invasion into
the surrounding stroma.2 DCIS is consid-
ered to be a non-obligate precursor of
invasive ductal carcinoma. Invasion might
occur when the surrounding breast
stroma, i.e. the ‘soil’ for potentially inva-
sive cancer cells, is prepared and cultivated
by the pre-invasive lesion, like a farmer
fertilizing his fields before seeding. The
close reciprocal relation between stromal
fibroblasts and transformed epithelial cells
induces extensive changes in the microen-
vironment.3 Stromal fibroblasts are con-
verted into corruptive cancer-associated
fibroblasts (CAFs) through cancer cell-
induced modifications of fibroblast signal-
ing pathways.4 Hence CAFs contribute to
the remodeling of the extracellular matrix
(ECM), which is likely to be required for
invasion since the normal breast stroma
functions as a protective barrier.3 Such an
altered peritumoral stroma is not only pre-
sumed to play a role in breast cancer pro-
gression, but also in therapy response.4
Alterations of the periductal stroma in
DCIS are reflected in a myxoid stromal
architecture, which is associated with an
increased recurrence risk. The presence of
myxoid periductal stroma strongly corre-
lates with reduced periductal decorin
expression in DCIS.5 Decorin, a member
of the small leucin-rich proteoglycan fam-
ily, is abundantly present in the breast
ECM and ‘decorates’ collagen. Decorin
plays a major role in the assembly of col-
lagen fibrils,6 and reduced expression
might contribute to the development of a
myxoid stromal architecture. We
attempted to clarify the pathogenesis of
myxoid stroma and the role of decorin in
this process, with an emphasis on the
paracrine regulation of ECM protein
expression. These studies revealed that
transforming growth factor b1 (TGF-b1)
and basic fibroblast growth factor (bFGF)
are 2 growth factors capable of potently
reducing decorin expression in CAFs.
Simultaneously, both growth factors
enhanced the expression of versican,
biglycan and type I collagen in CAFs,
albeit at different levels.7 Despite having
similar effects on the modulation of type
I collagen and the aforementioned pro-
teoglycans, TGF-b1 and bFGF differen-
tially regulated the expression of
a-smooth muscle actin (a-SMA), a
hypothesized marker of CAFs. TGF-b1
caused a strong upregulation, whereas
a-SMA was profoundly downregulated
by bFGF.7 This differential regulation
might explain why the presence of myx-
oid stroma in DCIS is associated with
stromal decorin expression but not with
periductal a-SMA expression.5
To explore whether breast cancer cell
lines were able to induce similar altera-
tions in ECM protein expression, CAFs
were treated with cancer cell-secretome
containing medium. Upon treatment
with different cancer cell secretomes, a
TGF-b1-like response was noted, in
which CAFs presented downregulation of
decorin expression and upregulation of
a-SMA, type I collagen, biglycan and
versican.7 As a proof of concept, immu-
nohistochemistry was performed on a
series of 20 DCIS specimens. This analy-
sis showed a trend toward periductal ver-
sican overexpression in DCIS with
myxoid stroma, although there was no
relation with stromal biglycan expres-
sion.7 Comparable with Paget’s ‘seed and
soil’ hypothesis about metastatic niches
for invasive breast cancers, we hypothesize
that some pre-invasive DCIS lesions pre-
pare the stroma for subsequent invasion.
Transformed epithelial cells, provisionally
confined to the ductal system, influence
their neighboring stroma by secretion of
growth factors (Fig. 1). Other mecha-
nisms, such as the secretion of proteases,
may further contribute to stromal
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remodeling by the degradation of ECM
proteins that otherwise prevent invasion.
Additionally, the differentiation of the
myoepithelial cell layer is hampered and
myoepithelial cells gradually disappear
during breast cancer progression. Cancer-
cell derived growth factors are likely to
influence adjacent fibroblasts to prevent
them from producing anti-invasive ECM
proteins, and thus prevent them from act-
ing hostile toward the pre-invasive lesion.
Instead, pro-invasive growth factors turn
fibroblasts into carcinoma-promoting
allies that pave the path for invasion.
Our hypothesis was further supported
by the anti-adhesive effects of decorin
coatings on breast cancer cell adhesion.7
The addition of type I collagen neutralized
the inhibition of adhesion by decorin.
Three-dimensional CAF-derived matrices
were applied to mimic the peritumoral
microenvironment.3 Cancer cells pre-
sented significantly enhanced spreading
when seeded on matrices derived from
TGF-b1 treated CAFs.7 Altogether these
data indicate that preinvasive DCIS
lesions might modulate the composition
of the neighboring breast stroma through
TGF-b1 release, to obtain an invasion-
permissive and carcinoma-promoting
microenvironment. This invasion-
enabling microenvironment is probably
reflected in myxoid stromal architecture.
Breast cancer progression is likely to be
accompanied by a tumor-induced imbal-
ance in the ECM composition. Additional
investigations on larger DCIS patient
cohorts are warranted to elucidate the
potential prognostic value of these stromal
changes, such as increased stromal versican
expression. Furthermore, TGF-b1 seems
an attractive candidate for targeted ther-
apy, and future research should explore
the role of TGF-b1 blockade in cancer
treatment.
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Figure 1. Ductal carcinoma in situ (DCIS) causes growth factor-induced transition of ﬁbroblasts into
cancer-associated ﬁbroblasts (CAF). CAF-induced ECM remodeling turns sclerotic stroma into myx-
oid stroma. Decreased decorin expression and increased versican expression may contribute to this
altered architecture. Alpha-smooth muscle actin (a-SMA) is differentially regulated by bFGF and
TGF-b1. This CAF-induced altered ECM composition paves the path for invasion.
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